• Tue, January 14, 2025
by: Emirates247
MoHESR and DEWA join forces to align the scholarship programme with national priorities
• Wed, January 15, 2025
by: Euronews
Kazakhstan's digital economy: Fintech growth, cashless payments, and cybercrime prevention
by: MSN
by: MSN
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's priorities might be on hot button issues such as drug pricing reforms and vaccines.

Read the Full Reuters Article at:
https://www.reuters.com/business/healthcare-pharmaceuticals/biopharma-industry-eyes-2025-bounceback-grapples-with-uncertainty-over-trump-2025-01-14/
